EQUALINE

Product NDC
41163-425
11-digit product format
411630425
Labeler code
41163
Product ID
41163-425_5c8348b6-2fcc-4e02-8dfb-6f7eb9b1b329
Type
HUMAN OTC DRUG
Nonproprietary name
PYRITHIONE ZINE
Dosage form
LIQUID
Route
TOPICAL
Labeler
SUPERVALU INC
Application
part358H
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2014-07-31
Marketing end
0000-00-00
Substance
PYRITHIONE ZINC
Active strength
10 mg/mL
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct41163-425IInactivated by FDA2026-10-21
excluded packagepackage41163-42541163-425-14IInactivated by FDA2026-10-21

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage41163-425-14d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage41163-425-14f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage41163-425-142ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage41163-425-14a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage41163-425-14cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage41163-425-14cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage41163-425-14302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage41163-425-14ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage41163-425-140efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage41163-425-14ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage41163-425-14367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage41163-425-14557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage41163-425-148af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage41163-425-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage41163-425-141332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage41163-425-14fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage41163-425-1486f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage41163-425-14bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage41163-425-148dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage41163-425-14e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage41163-425-149bebd1f3094a…5416666fcb17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
41163-425-142020-01-31C16284748780-19d75b9d0-7411-f424-e053-dadaa90a57ceDRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
41163-425-14EQUALINEDRY SCALP 2 IN 1420 mL in 1 BOTTLE, PLASTICLIQUID4201

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PYRITHIONE ZINCACTIVE INGREDIENTR953O2RHZ5EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
PYRITHIONE ZINCACTIVE MOIETYR953O2RHZ5EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
ALMOND OILINACTIVE INGREDIENT66YXD4DKO9EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
COCO MONOETHANOLAMIDEINACTIVE INGREDIENTC80684146DEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
GLYCOL DISTEARATEINACTIVE INGREDIENT13W7MDN21WEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (1.7 SUBSTITUENTS PER SACCHARIDE)INACTIVE INGREDIENTB16G315W7AEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
MAGNESIUM CARBONATE HYDROXIDEINACTIVE INGREDIENTYQO029V1L4EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
MAGNESIUM SULFATEINACTIVE INGREDIENTDE08037SABEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
METHYLCHLOROISOTHIAZOLINONEINACTIVE INGREDIENTDEL7T5QRPNEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
METHYLISOTHIAZOLINONEINACTIVE INGREDIENT229D0E1QFAEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
SODIUM LAURETH SULFATEINACTIVE INGREDIENTBPV390UAP0EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
SODIUM XYLENESULFONATEINACTIVE INGREDIENTG4LZF950UREQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
WATERINACTIVE INGREDIENT059QF0KO0REQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1
ZINC CARBONATEINACTIVE INGREDIENTEQR32Y7H0MEQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
41163-425EQUALINE DRY SCALP 2 IN 1 (PYRITHIONE ZINE) LIQUID [SUPERVALU INC]1Legacy NDC, 1 package rows20140801_324c84cb-eb11-43ce-ab81-5d786872dc61.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
41163-425-1441163042514420 mL in 1 BOTTLE, PLASTIC420 mlHistorical